Cargando…

Targeting urine output and 30-day mortality in goal-directed therapy: a systematic review with meta-analysis and meta-regression

BACKGROUND: Oliguria is associated with a decreased kidney- and organ perfusion, leading to organ damage and increased mortality. While the effects of correcting oliguria on renal outcome have been investigated frequently, whether urine output is a modifiable risk factor for mortality or simply an e...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Zee, Esther N., Egal, Mohamud, Gommers, Diederik, Groeneveld, A. B. Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303289/
https://www.ncbi.nlm.nih.gov/pubmed/28187752
http://dx.doi.org/10.1186/s12871-017-0316-4
_version_ 1782506683245789184
author van der Zee, Esther N.
Egal, Mohamud
Gommers, Diederik
Groeneveld, A. B. Johan
author_facet van der Zee, Esther N.
Egal, Mohamud
Gommers, Diederik
Groeneveld, A. B. Johan
author_sort van der Zee, Esther N.
collection PubMed
description BACKGROUND: Oliguria is associated with a decreased kidney- and organ perfusion, leading to organ damage and increased mortality. While the effects of correcting oliguria on renal outcome have been investigated frequently, whether urine output is a modifiable risk factor for mortality or simply an epiphenomenon remains unclear. We investigated whether targeting urine output, defined as achieving and maintaining urine output above a predefined threshold, in hemodynamic management protocols affects 30-day mortality in perioperative and critical care. METHODS: We performed a systematic review with a random-effects meta-analyses and meta-regression based on search strategy through MEDLINE, EMBASE and references in relevant articles. We included studies comparing conventional fluid management with goal-directed therapy and reporting whether urine output was used as target or not, and reporting 30-day mortality data in perioperative and critical care. RESULTS: We found 36 studies in which goal-directed therapy reduced 30-day mortality (OR 0.825; 95% CI 0.684-0.995; P = 0.045). Targeting urine output within goal-directed therapy increased 30-day mortality (OR 2.66; 95% CI 1.06-6.67; P = 0.037), but not in conventional fluid management (OR 1.77; 95% CI 0.59-5.34; P = 0.305). After adjusting for operative setting, hemodynamic monitoring device, underlying etiology, use of vasoactive medication and year of publication, we found insufficient evidence to associate targeting urine output with a change in 30-day mortality (goal-directed therapy: OR 1.17; 95% CI 0.54-2.56; P = 0.685; conventional fluid management: OR 0.74; 95% CI 0.39-1.38; P = 0.334). CONCLUSIONS: The principal finding of this meta-analysis is that after adjusting for confounders, there is insufficient evidence to associate targeting urine output with an effect on 30-day mortality. The paucity of direct data illustrates the need for further research on whether permissive oliguria should be a key component of fluid management protocols. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12871-017-0316-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5303289
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53032892017-02-15 Targeting urine output and 30-day mortality in goal-directed therapy: a systematic review with meta-analysis and meta-regression van der Zee, Esther N. Egal, Mohamud Gommers, Diederik Groeneveld, A. B. Johan BMC Anesthesiol Research Article BACKGROUND: Oliguria is associated with a decreased kidney- and organ perfusion, leading to organ damage and increased mortality. While the effects of correcting oliguria on renal outcome have been investigated frequently, whether urine output is a modifiable risk factor for mortality or simply an epiphenomenon remains unclear. We investigated whether targeting urine output, defined as achieving and maintaining urine output above a predefined threshold, in hemodynamic management protocols affects 30-day mortality in perioperative and critical care. METHODS: We performed a systematic review with a random-effects meta-analyses and meta-regression based on search strategy through MEDLINE, EMBASE and references in relevant articles. We included studies comparing conventional fluid management with goal-directed therapy and reporting whether urine output was used as target or not, and reporting 30-day mortality data in perioperative and critical care. RESULTS: We found 36 studies in which goal-directed therapy reduced 30-day mortality (OR 0.825; 95% CI 0.684-0.995; P = 0.045). Targeting urine output within goal-directed therapy increased 30-day mortality (OR 2.66; 95% CI 1.06-6.67; P = 0.037), but not in conventional fluid management (OR 1.77; 95% CI 0.59-5.34; P = 0.305). After adjusting for operative setting, hemodynamic monitoring device, underlying etiology, use of vasoactive medication and year of publication, we found insufficient evidence to associate targeting urine output with a change in 30-day mortality (goal-directed therapy: OR 1.17; 95% CI 0.54-2.56; P = 0.685; conventional fluid management: OR 0.74; 95% CI 0.39-1.38; P = 0.334). CONCLUSIONS: The principal finding of this meta-analysis is that after adjusting for confounders, there is insufficient evidence to associate targeting urine output with an effect on 30-day mortality. The paucity of direct data illustrates the need for further research on whether permissive oliguria should be a key component of fluid management protocols. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12871-017-0316-4) contains supplementary material, which is available to authorized users. BioMed Central 2017-02-10 /pmc/articles/PMC5303289/ /pubmed/28187752 http://dx.doi.org/10.1186/s12871-017-0316-4 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
van der Zee, Esther N.
Egal, Mohamud
Gommers, Diederik
Groeneveld, A. B. Johan
Targeting urine output and 30-day mortality in goal-directed therapy: a systematic review with meta-analysis and meta-regression
title Targeting urine output and 30-day mortality in goal-directed therapy: a systematic review with meta-analysis and meta-regression
title_full Targeting urine output and 30-day mortality in goal-directed therapy: a systematic review with meta-analysis and meta-regression
title_fullStr Targeting urine output and 30-day mortality in goal-directed therapy: a systematic review with meta-analysis and meta-regression
title_full_unstemmed Targeting urine output and 30-day mortality in goal-directed therapy: a systematic review with meta-analysis and meta-regression
title_short Targeting urine output and 30-day mortality in goal-directed therapy: a systematic review with meta-analysis and meta-regression
title_sort targeting urine output and 30-day mortality in goal-directed therapy: a systematic review with meta-analysis and meta-regression
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303289/
https://www.ncbi.nlm.nih.gov/pubmed/28187752
http://dx.doi.org/10.1186/s12871-017-0316-4
work_keys_str_mv AT vanderzeeesthern targetingurineoutputand30daymortalityingoaldirectedtherapyasystematicreviewwithmetaanalysisandmetaregression
AT egalmohamud targetingurineoutputand30daymortalityingoaldirectedtherapyasystematicreviewwithmetaanalysisandmetaregression
AT gommersdiederik targetingurineoutputand30daymortalityingoaldirectedtherapyasystematicreviewwithmetaanalysisandmetaregression
AT groeneveldabjohan targetingurineoutputand30daymortalityingoaldirectedtherapyasystematicreviewwithmetaanalysisandmetaregression